Your browser doesn't support javascript.
loading
Synthesis of a new water-soluble hexacarboxylated tribenzotriquinacene derivative and its competitive host-guest interaction for drug delivery.
Li, Man-Ping; Yang, Nan; Xu, Wen-Rong.
Affiliation
  • Li MP; Key Laboratory of Advanced Materials of Tropical Island Resources of Ministry of Education, Department of Chemistry, School of Science or School of Chemical Engineering and Technology, Hainan University, Haikou, 570228, China.
  • Yang N; Key Laboratory of Advanced Materials of Tropical Island Resources of Ministry of Education, Department of Chemistry, School of Science or School of Chemical Engineering and Technology, Hainan University, Haikou, 570228, China.
  • Xu WR; Key Laboratory of Advanced Materials of Tropical Island Resources of Ministry of Education, Department of Chemistry, School of Science or School of Chemical Engineering and Technology, Hainan University, Haikou, 570228, China.
Beilstein J Org Chem ; 18: 539-548, 2022.
Article in En | MEDLINE | ID: mdl-35615534
ABSTRACT
A new water-soluble hexacarboxylated tribenzotriquinacene derivative (TBTQ-CB6) was synthesized and used as a supramolecular drug carrier to load the model anticancer drugs dimethyl viologen (MV) and doxorubicin (DOX) via host-guest interactions. The drugs could be effectively released by spermine (SM), a molecule overexpressed in cancer cells, through host-guest competitive substitution since TBTQ-CB6 has a stronger binding affinity toward SM than MV and DOX. The host-guest interactions of the complexes of TBTQ-CB6 with MV, DOX and SM were investigated by NMR spectroscopy and fluorescence spectroscopy. The association stoichiometry of the complexes of TBTQ-CB6 with MV, DOX, and SM was found to be 11 with association constants of K a = (7.67 ± 0.34) × 104 M-1, K a = (6.81 ± 0.33) × 104 M-1, and K a = (5.09 ± 0.98) × 105 M-1, respectively. The competitive substitution process was visualized by NMR titration. This novel TBTQ-based host-guest drug delivery system may have potential use in supramolecular chemotherapy.
Key words